[ad_1]
G42, a leading artificial intelligence company based in the UAE, and Mubadala, an Abu Dhabi sovereign investor, will combine their healthcare businesses to create a new, first-of-its-kind integrated healthcare company.
By combining G42 Healthcare’s unique medical and data-centric technology with Mubadala Health’s world-class patient care, the new entity will seek to revolutionize the regional healthcare landscape and deliver a new kind of personalized, patient-centric Nursing method.
Both organizations already serve hundreds of thousands of patients each year. The new entity will leverage the strengths of this joint network, including state-of-the-art medical facilities and digital platforms, to enhance patient services throughout the care continuum.
Frontiers of Medical Research
At the forefront of medical research and innovation, the new company will be a vertically integrated healthcare powerhouse delivering groundbreaking clinical solutions that help solve the world’s most critical health and diagnostic challenges. Hasan Jasem Al Nowais has been appointed CEO of the new entity and will continue to lead Mubadala Health.
Peng Xiao, CEO of G42 Group, said: “We aim to leverage on the respective strengths of G42 Healthcare and Mubadala Health to unlock medical superintelligence and facilitate global medical expansion. Our capabilities and experience in leveraging data and artificial intelligence will enable us to continue to Transforming the traditional healthcare ecosystem to deliver best-in-class patient care driven by the latest breakthrough research—all in world-class facilities.”
Waleed Al Mokarrab Al Muhairi, Chairman of Mubadala Health and Deputy Chief Executive Officer of Mubadala, said: “The future of healthcare lies in the incredible rapid advancement of technology. For more than a decade, Mubadala has invested in UAE residents provide the highest standard of patient care. We now seek to take patient care to the next level, entering a new era of precision and personalized medicine.”
Optimizing Clinical Outcomes
Al Nowais said: “The new company represents a truly integrated healthcare ecosystem where research, technology, artificial intelligence and genomics combine with world-class care to optimize clinical outcomes. We are committed to ensuring that our exceptional physicians and Teams of paramedics have access to advanced medical technology and provide unparalleled patient care.”
While continuing to build its network in the UAE, the new company will consider opportunities for international expansion and new partnerships. The new entity will also focus on collaborations with leading researchers and the pharmaceutical and healthtech ecosystems, leveraging the UAE’s advanced and future-proof regulatory framework to bring world-class healthcare to the local community.
Across both organisations, healthcare assets today include: Imperial College London Diabetes Centre; Health Point; National Reference Laboratory; Health Plus; Danat Al Emarat; Moorfields Eye Hospital Abu Dhabi; Bio-Guinness; Emirates Omics Center of Excellence; and Insights Research Organization & Solutions (IROS), the UAE’s first contract research organization specializing in healthcare research. — trade arab news agency
[ad_2]
Source link